These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16011254)

  • 41. Highly twisted adamantyl arotinoids: synthesis, antiproliferative effects and RXR transactivation profiles.
    Pérez-Rodríguez S; Ortiz MA; Pereira R; Rodríguez-Barrios F; de Lera AR; Piedrafita FJ
    Eur J Med Chem; 2009 Jun; 44(6):2434-46. PubMed ID: 19216008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Possible Molecular Interactions of Bexarotene - A Retinoid Drug and Alzheimer's Aβ Peptide: A Docking Study.
    Mirza Z; Beg MA
    Curr Alzheimer Res; 2017; 14(3):327-334. PubMed ID: 27842487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preclinical PET Neuroimaging of [11C]Bexarotene.
    Rotstein BH; Placzek MS; Krishnan HS; Pekošak A; Collier TL; Wang C; Liang SH; Burstein ES; Hooker JM; Vasdev N
    Mol Imaging; 2016; 15():. PubMed ID: 27553293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bexarotene via CBP/p300 induces suppression of NF-κB-dependent cell growth and invasion in thyroid cancer.
    Cras A; Politis B; Balitrand N; Darsin-Bettinger D; Boelle PY; Cassinat B; Toubert ME; Chomienne C
    Clin Cancer Res; 2012 Jan; 18(2):442-53. PubMed ID: 22142826
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure-activity relationship study on benzoic acid part of diphenylamine-based retinoids.
    Ohta K; Kawachi E; Shudo K; Kagechika H
    Bioorg Med Chem Lett; 2013 Jan; 23(1):81-4. PubMed ID: 23217961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function.
    Nahoum V; Pérez E; Germain P; Rodríguez-Barrios F; Manzo F; Kammerer S; Lemaire G; Hirsch O; Royer CA; Gronemeyer H; de Lera AR; Bourguet W
    Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17323-8. PubMed ID: 17947383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene.
    Inoue M; Tanabe H; Nakashima K; Ishida Y; Kotani H
    J Nat Prod; 2014 Jul; 77(7):1670-7. PubMed ID: 24959987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention.
    Kong G; Kim HT; Wu K; DeNardo D; Hilsenbeck SG; Xu XC; Lamph WW; Bissonnette R; Dannenberg AJ; Brown PH
    Cancer Res; 2005 Apr; 65(8):3462-9. PubMed ID: 15833882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Synthesis of retinoids with a modified polar group and their antitumor activity. Report I].
    Deriabina EL; Khodonov AA; Cherevataia GV; Kirillova IuG; Shvets VI; Kostanian IA; Astapova MV; Dranitsyna SM; Starovoĭtova EV
    Bioorg Khim; 1995 Dec; 21(12):941-9. PubMed ID: 8602891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands.
    Elmazar MM; Nau H
    Arch Toxicol; 2004 Nov; 78(11):660-8. PubMed ID: 15558240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. All-trans retinoic acid enhances the transport of phase II metabolites of benzo[a]pyrene by inducing the Breast Cancer Resistance Protein expression in Caco-2 cells.
    Hessel S; Lampen A
    Toxicol Lett; 2010 Aug; 197(2):151-5. PubMed ID: 20562004
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spatiotemporal retinoid-X receptor activation detected in live vertebrate embryos.
    Luria A; Furlow JD
    Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8987-92. PubMed ID: 15178767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes.
    Lømo J; Smeland EB; Ulven S; Natarajan V; Blomhoff R; Gandhi U; Dawson MI; Blomhoff HK
    J Cell Physiol; 1998 Apr; 175(1):68-77. PubMed ID: 9491782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Retinoids: mechanisms of action].
    Berbis P
    Ann Dermatol Venereol; 2010 Nov; 137 Suppl 3():S97-103. PubMed ID: 21185985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 9-cis-retinoic acid induces neuronal differentiation of retinoic acid-nonresponsive embryonal carcinoma cells.
    Yokota Y; Ohkubo H
    Exp Cell Res; 1996 Oct; 228(1):1-7. PubMed ID: 8892963
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthetic retinoids: recent developments concerning structure and clinical utility.
    Kagechika H; Shudo K
    J Med Chem; 2005 Sep; 48(19):5875-83. PubMed ID: 16161990
    [No Abstract]   [Full Text] [Related]  

  • 57. RAR and RXR modulation in cancer and metabolic disease.
    Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Density functional and docking studies of retinoids for cancer treatment.
    Silva CH; Almeida P; Taft CA
    J Mol Model; 2004 Feb; 10(1):38-43. PubMed ID: 14634847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful treatment of angioimmunoblastic T-cell lymphoma with the retinoid X receptor agonist, bexarotene.
    Tsai DE; Chong E; Bagg A; Arnoldi S; Svoboda J; Nasta S; Schuster SJ
    Leuk Lymphoma; 2011 Sep; 52(9):1815-7. PubMed ID: 21585279
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of selective retinoic acid receptor- and retinoic X receptor-mediated efficacy, tolerance, and survival in cutaneous t-cell lymphoma.
    Querfeld C; Rosen ST; Guitart J; Rademaker A; Fung BB; Posten W; Kuzel TM
    J Am Acad Dermatol; 2004 Jul; 51(1):25-32. PubMed ID: 15243520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.